Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis

被引:0
|
作者
Meliha Crnkic Kapetanovic
Tore Saxne
Göran Jönsson
Lennart Truedsson
Pierre Geborek
机构
[1] Lund University,Department of Clinical Sciences Lund, Section of Rheumatology
[2] Lund University,Department of Clinical Sciences Lund, Section of Infectious Diseases
[3] Lund University,Department of Laboratory Medicine, Section of Microbiology, Immunology and Glycobiology
来源
Arthritis Research & Therapy | / 15卷
关键词
Rheumatoid Arthritis Patient; Tocilizumab; Abatacept; Invasive Pneumococcal Disease; Pneumococcal Conjugate Vaccine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [11] Comparison of the clinical effectiveness of tumour necrosis factor inhibitors and abatacept after insufficient response to tocilizumab in patients with rheumatoid arthritis
    Mitsuhiro Akiyama
    Yuko Kaneko
    Harumi Kondo
    Tsutomu Takeuchi
    Clinical Rheumatology, 2016, 35 : 2829 - 2834
  • [12] Comparison of the clinical effectiveness of tumour necrosis factor inhibitors and abatacept after insufficient response to tocilizumab in patients with rheumatoid arthritis
    Akiyama, Mitsuhiro
    Kaneko, Yuko
    Kondo, Harumi
    Takeuchi, Tsutomu
    CLINICAL RHEUMATOLOGY, 2016, 35 (11) : 2829 - 2834
  • [13] Comparison of Rheumatoid Arthritis Patients' 2-Year Infliximab, Abatacept, and Tocilizumab Persistence Rates
    Diep, Laetitia
    Barbier, Vincent
    Doussiere, Marie
    Touboul, Estelle
    Jesson, Claire
    Deprez, Valentine
    Sobhy-Danial, Jean-Marc
    Fardellone, Patrice
    Goeb, Vincent
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
  • [14] Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity
    Nobunori Takahashi
    Toshihisa Kojima
    Atsushi Kaneko
    Daihei Kida
    Yuji Hirano
    Takayoshi Fujibayashi
    Yuichiro Yabe
    Hideki Takagi
    Takeshi Oguchi
    Hiroyuki Miyake
    Takefumi Kato
    Naoki Fukaya
    Hisato Ishikawa
    Masatoshi Hayashi
    Seiji Tsuboi
    Yasuhide Kanayama
    Daizo Kato
    Koji Funahashi
    Hiroyuki Matsubara
    Yosuke Hattori
    Masahiro Hanabayashi
    Shinya Hirabara
    Kenya Terabe
    Yutaka Yoshioka
    Naoki Ishiguro
    Clinical Rheumatology, 2014, 33 : 39 - 47
  • [15] Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity
    Takahashi, Nobunori
    Kojima, Toshihisa
    Kaneko, Atsushi
    Kida, Daihei
    Hirano, Yuji
    Fujibayashi, Takayoshi
    Yabe, Yuichiro
    Takagi, Hideki
    Oguchi, Takeshi
    Miyake, Hiroyuki
    Kato, Takefumi
    Fukaya, Naoki
    Ishikawa, Hisato
    Hayashi, Masatoshi
    Tsuboi, Seiji
    Kanayama, Yasuhide
    Kato, Daizo
    Funahashi, Koji
    Matsubara, Hiroyuki
    Hattori, Yosuke
    Hanabayashi, Masahiro
    Hirabara, Shinya
    Terabe, Kenya
    Yoshioka, Yutaka
    Ishiguro, Naoki
    CLINICAL RHEUMATOLOGY, 2014, 33 (01) : 39 - 47
  • [16] Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
    Hirabara, Shinya
    Takahashi, Nobunori
    Fukaya, Naoki
    Miyake, Hiroyuki
    Yabe, Yuichiro
    Kaneko, Atsushi
    Ito, Takayasu
    Oguchi, Takeshi
    Kida, Daihei
    Hirano, Yuji
    Fujibayashi, Takayoshi
    Sugiura, Fumiaki
    Hayashi, Masatoshi
    Funahashi, Koji
    Hanabayashi, Masahiro
    Asai, Shuji
    Ishiguro, Naoki
    Kojima, Toshihisa
    CLINICAL RHEUMATOLOGY, 2014, 33 (09) : 1247 - 1254
  • [17] Clinical efficacy of abatacept, tocilizumab, and etanercept in Japanese rheumatoid arthritis patients with inadequate response to anti-TNF monoclonal antibodies
    Shinya Hirabara
    Nobunori Takahashi
    Naoki Fukaya
    Hiroyuki Miyake
    Yuichiro Yabe
    Atsushi Kaneko
    Takayasu Ito
    Takeshi Oguchi
    Daihei Kida
    Yuji Hirano
    Takayoshi Fujibayashi
    Fumiaki Sugiura
    Masatoshi Hayashi
    Koji Funahashi
    Masahiro Hanabayashi
    Shuji Asai
    Naoki Ishiguro
    Toshihisa Kojima
    Clinical Rheumatology, 2014, 33 : 1247 - 1254
  • [18] Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysis
    Alisson Pugliesi
    Amanda Borges de Oliveira
    Ana Beatrice Oliveira
    Ricardo Xavier
    Licia Maria Henrique da Mota
    Manoel Barros Bertolo
    Miguel Angel Gonzalez-Gay
    Gustavo Citera
    Luiz Sergio Fernandes de Carvalho
    Advances in Rheumatology, 63
  • [19] Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysis
    Pugliesi, Alisson
    de Oliveira, Amanda Borges
    Oliveira, Ana Beatrice
    Xavier, Ricardo
    Henrique da Mota, Licia Maria
    Bertolo, Manoel Barros
    Gonzalez-Gay, Miguel Angel
    Citera, Gustavo
    Fernandes de Carvalho, Luiz Sergio
    ADVANCES IN RHEUMATOLOGY, 2023, 63 (01)
  • [20] Abatacept and tocilizumab tapering in rheumatoid arthritis patients: results of SONATA-a retrospective, exploratory cohort study
    Bouman, Chantal A. M.
    Tweehuysen, Lieke
    Haverkort, Dieneke
    van den Ende, Cornelia H.
    van der Maas, Aatke
    den Broeder, Alfons A.
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2018, 2 (01) : 1 - 10